Thomas Tropea, DO
Enriched profileChief Medical Officer, Institute for Neurodegenerative Disorders · Institute for Neurodegenerative Disorders
Thomas Tropea is Chief Medical Officer, Institute for Neurodegenerative Disorders at Institute for Neurodegenerative Disorders. OpenAlex indexes 123 publications with 2,371 citations (h-index 28); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Thomas Tropea, DO, is Chief Medical Officer, Institute for Neurodegenerative Disorders. The public record shows 123 publications with 2,371 citations (h-index 28), centered on Parkinson's Disease Mechanisms and Treatments, Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 2 companies, 1 NIH-funded awards (2020–2024).
- Most recent indexed publication: 2026 · Annals of neurology
- Top research focus: Parkinson's Disease Mechanisms and Treatments
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 30 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 52.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- GEnetic Counseling Through Virtual Visits in Parkinson's Disease
Sponsor: University of Pennsylvania
Industry payments
Updated 16 Oct 2026
2 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20221 payment
- AbbVie Inc.Program year20211 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
98.7%Aromatic Amino Acid Decarboxylation Inhibitor44.3%Carbidopa-Levodopa85%Carbidopa-Levodopa Er11%Carbidopa-Levodopa-Entacapone4%Part D<11 patientsMonoamine Oxidase Inhibitor12.4%Rasagiline Mesylate78%Selegiline Hcl22%Part D<11 patients+ 10 more classes in this area
Cardiovascular
1.3%Beta blocker1.3%Propranolol Hcl Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- The Role of Alzheimer's Disease Genetic Risk in Predicting Parkinson's Disease Dementia
University of Pennsylvania
FY2024$209,063K23NS114167 - The Role of Alzheimer's Disease Genetic Risk in Predicting Parkinson's Disease Dementia
University of Pennsylvania
FY2023$209,063K23NS114167 - The Role of Alzheimer's Disease Genetic Risk in Predicting Parkinson's Disease Dementia
University of Pennsylvania
FY2022$187,652K23NS114167
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Patient-reported outcomes for remote and in-person visits for genetic counseling in adult neurology.
Journal of genetic counseling
Article2025 - Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes.
Annals of clinical and translational neurology
Article2025
Most-cited works
by citation count (OpenAlex)- 01Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseArticle171 citations2021
- 02GPNMB confers risk for Parkinson’s disease through interaction with α-synucleinArticle158 citations2022
- 03A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathologyArticle120 citations2021
- 04Parkinson’s disease variant detection and disclosure: PD GENEration, a North American studyArticle108 citations2024
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/thomas-tropea-do
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
pmwcintl.com/speaker/thomas-tropea-132_institute-for-neurodegenerative-disorders_2027sv
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pmwcintl.com ↗ - Other
michaeljfox.org/podcast/exploring-link-between-parkinsons-and-alzheimers-webinar-audio
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →michaeljfox.org ↗ - Other
michaeljfox.org/researcher/thomas-f-tropea-do-mph-mstr
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →michaeljfox.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Assistant Professor of Neurology
Perelman School of Medicine, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - The MIND Initiative
Penn Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →michaeljfox.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Donald Royall, MD
Institute for Neurodegenerative Disorders
David Russell, MD, PhD
Institute for Neurodegenerative Disorders
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida